227 related articles for article (PubMed ID: 22028322)
1. Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers.
Yuan JM; Gao YT; Murphy SE; Carmella SG; Wang R; Zhong Y; Moy KA; Davis AB; Tao L; Chen M; Han S; Nelson HH; Yu MC; Hecht SS
Cancer Res; 2011 Nov; 71(21):6749-57. PubMed ID: 22028322
[TBL] [Abstract][Full Text] [Related]
2. Urinary tobacco smoke-constituent biomarkers for assessing risk of lung cancer.
Yuan JM; Butler LM; Stepanov I; Hecht SS
Cancer Res; 2014 Jan; 74(2):401-11. PubMed ID: 24408916
[TBL] [Abstract][Full Text] [Related]
3. Tobacco-specific N-nitrosamine exposures and cancer risk in the Shanghai Cohort Study: remarkable coherence with rat tumor sites.
Stepanov I; Sebero E; Wang R; Gao YT; Hecht SS; Yuan JM
Int J Cancer; 2014 May; 134(10):2278-83. PubMed ID: 24243522
[TBL] [Abstract][Full Text] [Related]
4. Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers.
Yuan JM; Koh WP; Murphy SE; Fan Y; Wang R; Carmella SG; Han S; Wickham K; Gao YT; Yu MC; Hecht SS
Cancer Res; 2009 Apr; 69(7):2990-5. PubMed ID: 19318550
[TBL] [Abstract][Full Text] [Related]
5. High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers.
Carmella SG; Ming X; Olvera N; Brookmeyer C; Yoder A; Hecht SS
Chem Res Toxicol; 2013 Aug; 26(8):1209-17. PubMed ID: 23837805
[TBL] [Abstract][Full Text] [Related]
6. Tobacco smoke biomarkers and cancer risk among male smokers in the Shanghai cohort study.
Hecht SS; Murphy SE; Stepanov I; Nelson HH; Yuan JM
Cancer Lett; 2013 Jun; 334(1):34-8. PubMed ID: 22824243
[TBL] [Abstract][Full Text] [Related]
7. Temporal stability of urinary and plasma biomarkers of tobacco smoke exposure among cigarette smokers.
Church TR; Anderson KE; Le C; Zhang Y; Kampa DM; Benoit AR; Yoder AR; Carmella SG; Hecht SS
Biomarkers; 2010 Jun; 15(4):345-52. PubMed ID: 20374068
[TBL] [Abstract][Full Text] [Related]
8. A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers.
Church TR; Anderson KE; Caporaso NE; Geisser MS; Le CT; Zhang Y; Benoit AR; Carmella SG; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):260-6. PubMed ID: 19124507
[TBL] [Abstract][Full Text] [Related]
9. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.
Derby KS; Cuthrell K; Caberto C; Carmella S; Murphy SE; Hecht SS; Le Marchand L
Int J Cancer; 2009 Nov; 125(10):2418-24. PubMed ID: 19598261
[TBL] [Abstract][Full Text] [Related]
10. Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes.
Hecht SS; Murphy SE; Carmella SG; Li S; Jensen J; Le C; Joseph AM; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):693-8. PubMed ID: 15767351
[TBL] [Abstract][Full Text] [Related]
11. The ratio of a urinary tobacco-specific lung carcinogen metabolite to cotinine is significantly higher in passive than in active smokers.
Vogel RI; Carmella SG; Stepanov I; Hatsukami DK; Hecht SS
Biomarkers; 2011 Sep; 16(6):491-7. PubMed ID: 21812592
[TBL] [Abstract][Full Text] [Related]
12. Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke.
Anderson KE; Carmella SG; Ye M; Bliss RL; Le C; Murphy L; Hecht SS
J Natl Cancer Inst; 2001 Mar; 93(5):378-81. PubMed ID: 11238699
[TBL] [Abstract][Full Text] [Related]
13. Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers.
Yuan JM; Knezevich AD; Wang R; Gao YT; Hecht SS; Stepanov I
Carcinogenesis; 2011 Sep; 32(9):1366-71. PubMed ID: 21734256
[TBL] [Abstract][Full Text] [Related]
14. CYP2A6 genetic polymorphisms and biomarkers of tobacco smoke constituents in relation to risk of lung cancer in the Singapore Chinese Health Study.
Yuan JM; Nelson HH; Carmella SG; Wang R; Kuriger-Laber J; Jin A; Adams-Haduch J; Hecht SS; Koh WP; Murphy SE
Carcinogenesis; 2017 Apr; 38(4):411-418. PubMed ID: 28182203
[TBL] [Abstract][Full Text] [Related]
15. Urine cotinine underestimates exposure to the tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in passive compared with active smokers.
Benowitz N; Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2795-800. PubMed ID: 20805316
[TBL] [Abstract][Full Text] [Related]
16. Combined analysis of r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in smokers' plasma.
Carmella SG; Yoder A; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1490-4. PubMed ID: 16896038
[TBL] [Abstract][Full Text] [Related]
17. Uptake of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by Moldovan children.
Stepanov I; Hecht SS; Duca G; Mardari I
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):7-11. PubMed ID: 16434579
[TBL] [Abstract][Full Text] [Related]
18. Exposure to different sources of second-hand smoke during pregnancy and its effect on urinary cotinine and tobacco-specific nitrosamine (NNAL) concentrations.
Vardavas CI; Fthenou E; Patelarou E; Bagkeris E; Murphy S; Hecht SS; Connolly GN; Chatzi L; Kogevinas M
Tob Control; 2013 May; 22(3):194-200. PubMed ID: 22253001
[TBL] [Abstract][Full Text] [Related]
19. Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).
Ter-Minassian M; Asomaning K; Zhao Y; Chen F; Su L; Carmella SG; Lin X; Hecht SS; Christiani DC
Int J Cancer; 2012 Mar; 130(6):1338-46. PubMed ID: 21544809
[TBL] [Abstract][Full Text] [Related]
20. Urinary metabolites of a polycyclic aromatic hydrocarbon and volatile organic compounds in relation to lung cancer development in lifelong never smokers in the Shanghai Cohort Study.
Yuan JM; Butler LM; Gao YT; Murphy SE; Carmella SG; Wang R; Nelson HH; Hecht SS
Carcinogenesis; 2014 Feb; 35(2):339-45. PubMed ID: 24148823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
